Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neostigmine Antagonism of Mivacurium
NCT03019835Completed
- Sponsor
- Université libre de Bruxelles
- Start
- Dec 2016
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of neostigmine in neuromuscular blockade (NMB) (5 arms), sponsored by Université libre de Bruxelles. Primary endpoint: Change in Train Of Four measure at 15 months. Started Dec 2016; status: completed.
02
Drugs
neostigmine
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT03019835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03019835.